Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 16, 2017
Emerging Company Profile
Metabolic regulation
...Corporate partners: None Number of employees: 6 Funds raised: $11 million Investors: Intervest, SL Investment,
NHN Investment
...
Read More
BioCentury
|
Mar 9, 2017
Financial News
ImmunoMet Therapeutics completes venture financing
...Texas) raised $5 million in a series B round. New investors Intervest, SL Investment and
NHN Investment
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Jun 16, 2017
Emerging Company Profile
Metabolic regulation
...Corporate partners: None Number of employees: 6 Funds raised: $11 million Investors: Intervest, SL Investment,
NHN Investment
...
Read More
BioCentury
|
Mar 9, 2017
Financial News
ImmunoMet Therapeutics completes venture financing
...Texas) raised $5 million in a series B round. New investors Intervest, SL Investment and
NHN Investment
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page